학회지

학회지

  • HOME
  • 학회지
  • 학회지
  • 권호별 검색
Original Article
2026; 25 141 - 151/dnd-25-141.pdf 전문보기
Diagnostic Accuracy of MRI-Based Artificial Intelligence Models for Distinguishing Alzheimer's Disease and Mild Cognitive Impairment From Cognitively Normal Controls: A Systematic Review and Meta-Analysis

Sara Mahmoud Ibrahim Allaham
Department of Neurology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China


2026; 25 141 - 151
Alzheimer Disease; Mild Cognitive Impairment; Dementia; Magnetic Resonance Imaging; Artificial Intelligence; Deep Learning;
Original Article
2026; 25 152 - 163/dnd-25-152.pdf 전문보기
Druggable Pathophysiologic Targets in Alzheimer Disease: From Amyloid and Tau to Biomarker-Guided Multimodal Therapy

Jiwon Park
College of Pharmacy and Institute for Drug Research, Yeungnam University, Gyeongsan, Korea


2026; 25 152 - 163
Alzheimer Disease; Amyloid Beta-Peptides; Tau Proteins; Neuroinflammation; Biomarkers; Therapeutics;
Original Article
2026; 25 164 - 177/dnd-25-164.pdf 전문보기
National Age- and Education-Specific Normative Data for K-MoCA Total Score, Domain Index Scores, and K-MoCA-22

Yeonwook Kang ,1 Seungmin Jahng ,2 Minji Song 3
1Department of Psychology, College of Social Sciences, Hallym University, Chuncheon, Korea 2Department of Psychology, College of Social Sciences, Sungkyunkwan University, Seoul, Korea 3Hallym Applied Psychology Research Institute, Hallym University, Chuncheon, Korea


2026; 25 164 - 177
K-MoCA; K-MoCA-22; Normative Data; Domain Index Scores; Cognitive Screening;
Original Article
2026; 25 178 - 190/dnd-25-178.pdf 전문보기
Gait Analysis Using Wearable Sensors in Patients With Alzheimer’s Dementia: A Preliminary Report

Saenal Lee ,1 Sung-Ho Woo ,2 Ki Chang Nam ,3 Changon Moon ,4 Kwangmo Lee ,4 Kwang Ki Kim ,1,2 Hang-Rai Kim ,1,2,5 Jeewon Suh 1
1Department of Neurology, Dongguk University Ilsan Hospital, Goyang, Korea 2Institute of Interdisciplinary Brain Science, Dongguk University College of Medicine, Goyang, Korea 3Department of Medical Engineering, Dongguk University College of Medicine, Goyang, Korea 4Smart Medical Device Co., Ltd., Goyang, Korea 5ROA Neurology Clinic, Seongnam, Korea


2026; 25 178 - 190
Alzheimer Disease; Gait; Wearable Electronic Devices; Cognition;
Original Article
2026; 25 191 - 193/dnd-25-191.pdf 전문보기
A Case of Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia mimicking Multiple Sclerosis

191 Dear Editor, Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) is a rare, autosomal dominant white matter disorder that presents with cognitive decline, parkinsonism, pyramidal signs, and gait disturbance.1 Early diagnosis is often challenging due to its heterogeneous clinical presentation. A 34-year-old woman presented with right-sided weakness and gait disturbance. Six months later, she developed dysarthria and dysphagia. Neurological examination showed mild weakness (Medical Research Council grade 4) in the right upper and lower extremities and hyperreflexia in both legs. Sensory examination was normal, and cognition was relatively preserved. Brain magnetic resonance imaging (MRI) revealed multiple bilateral T2 hyperintense lesions involving the periventricular, juxtacortical, and deep white matter, with diffusion restriction on diffusion-weighted imaging without splenial involvement or calcification (Fig. 1A and B). Cerebrospinal fluid analysis showed normal cell count and protein level, with negative oligoclonal bands. Serum aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies were negative. Based on the 2017 McDonald criteria, she was initially diagnosed with relapsing-remitting multiple sclerosis (MS). Dissemination in space was fulfilled by the presence of periventricular and juxtacortical lesions, while dissemination in time was based on two clinical attacks occurring six months apart (right-sided weakness followed by dysarthria and dysphagia).2 The patient was treated with intravenous methylprednisolone followed by teriflunomide. Despite sequential treatment with dimethyl fumarate, cladribine, and rituximab, her symptoms progressively worsened. Behavioral and personality changes emerged, including emotional lability, perseveration, and impaired emotional control. At 14 months, follow-up brain MRI demonstrated progressive bilateral frontal-predominant white matter lesions, corpus callosum thinning, and persistent diffusion restriction (Fig. 1C and D). The Mini-Mental State Examination score declined from 25/30 at 26 months to 23/30 at 34 months despite 16 years of education. She became bedridden within 3 years after onset. Given the rapid progression, poor response to multiple immunotherapies, prominent frontal involvement, evolving cognitive and behavioral symptoms, and persistent diffusion Dement Neurocogn Disord. 2026 Jul;25(3):191-193 https://doi.org/10.12779/dnd.2026.25.3.191 pISSN 1738-1495·eISSN 2384-0757 A Case of Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia mimicking Multiple Sclerosis Letter to the Editor Received: May 11, 2026 Revised: Jul 3, 2026 Accepted: Jul 12, 2026 Published online: Jul 20, 2026 Correspondence to Hee Jin Kim Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea. Email: evekhj@gmail.com Ju-Hong Min Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea. Email: juhongm@skku.edu © 2026 The Author(s). Published by the Korean Dementia Association. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. ORCID iDs Suyeon Seo https://orcid.org/0000-0002-0972-5871 Ja-Hyun Jang https://orcid.org/0000-0003-0516-4947 Hee Jin Kim https://orcid.org/0000-0002-3186-9441
1 Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea 2Neuroscience Center, Samsung Medical Center, Seoul, Korea 3Department of Laboratory Medicine and Genetics, Samsung Medical Center, Seoul, Korea 4Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea


2026; 25 191 - 193
;
Original Article
2026; 25 194 - 194/dnd-25-194.pdf 전문보기
Erratum: Effects of Sarcopenia and Frailty on Cognitive Function, Brain Volume, and Dementia Risk: A Prospective Cohort Study Based on UK Biobank

Seok-Jae Heo ,1 Min Young Chun 2,3,4
1 Division of Biostatistics, Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Korea 2Department of Neurology, Yonsei University College of Medicine, Seoul, Korea 3Department of Neurology, Yongin Severance Hospital, Yonsei University Health System, Yongin, Korea 4Yonsei Beyond Lab, Yongin, Korea


2026; 25 194 - 194
;